Showing 1 to 9 of 9 results


Climate Change Exacerbates Neurological Disorders, Increasing Mortality and Morbidity"
Rising global temperatures worsen neurological disorders like epilepsy and increase stroke deaths; heat waves cause more seizures in vulnerable individuals and exacerbate conditions like multiple sclerosis; climate change poses a significant public health challenge.
Climate Change Exacerbates Neurological Disorders, Increasing Mortality and Morbidity"
Rising global temperatures worsen neurological disorders like epilepsy and increase stroke deaths; heat waves cause more seizures in vulnerable individuals and exacerbate conditions like multiple sclerosis; climate change poses a significant public health challenge.
Progress
48% Bias Score


Williams Syndrome: Extreme Friendliness and its Genetic Roots
Williams syndrome (WS), affecting 1 in 7,500, causes excessive friendliness towards strangers due to a deletion of 25-27 genes on chromosome 7, impacting brain development and potentially oxytocin levels; research explores GTF2I's role and potential clemastine treatment.
Williams Syndrome: Extreme Friendliness and its Genetic Roots
Williams syndrome (WS), affecting 1 in 7,500, causes excessive friendliness towards strangers due to a deletion of 25-27 genes on chromosome 7, impacting brain development and potentially oxytocin levels; research explores GTF2I's role and potential clemastine treatment.
Progress
32% Bias Score


Strolll Secures £10 Million to Expand AR-Based Neurorehabilitation
Strolll, a UK digital therapeutics startup using AR glasses for neurorehabilitation, secured £10 million in funding from IW Capital to expand sales, products, and target additional disorders; clinical trials show seven times treatment and two-thirds less staff time.
Strolll Secures £10 Million to Expand AR-Based Neurorehabilitation
Strolll, a UK digital therapeutics startup using AR glasses for neurorehabilitation, secured £10 million in funding from IW Capital to expand sales, products, and target additional disorders; clinical trials show seven times treatment and two-thirds less staff time.
Progress
60% Bias Score


BBVA Award Recognizes GLP-1 Hormone Discoverers for Diabetes, Obesity Treatments
The BBVA Foundation Frontiers of Knowledge Award in Biomedicine was given to four researchers for their discovery of the GLP-1 hormone's role in glucose regulation, appetite, and its implications for treating type 2 diabetes, obesity, and neurodegenerative diseases.
BBVA Award Recognizes GLP-1 Hormone Discoverers for Diabetes, Obesity Treatments
The BBVA Foundation Frontiers of Knowledge Award in Biomedicine was given to four researchers for their discovery of the GLP-1 hormone's role in glucose regulation, appetite, and its implications for treating type 2 diabetes, obesity, and neurodegenerative diseases.
Progress
32% Bias Score


Successful Epilepsy Surgery After Misdiagnosis
Isaac Klapper, 18, underwent successful brain surgery on March 8, 2024, at the Cleveland Clinic to remove a cortical dysplasia causing epilepsy after years of misdiagnosis and medication failure, resolving his seizures and enabling him to focus on his future.
Successful Epilepsy Surgery After Misdiagnosis
Isaac Klapper, 18, underwent successful brain surgery on March 8, 2024, at the Cleveland Clinic to remove a cortical dysplasia causing epilepsy after years of misdiagnosis and medication failure, resolving his seizures and enabling him to focus on his future.
Progress
44% Bias Score

Dance Shown to Improve Psychological and Cognitive Health More Than Other Exercise
A meta-analysis of 27 studies involving 1,392 participants reveals that structured dance interventions lasting at least six weeks significantly improve psychological and cognitive health, potentially exceeding the benefits of other forms of exercise, particularly regarding motivation and adherence; ...

Dance Shown to Improve Psychological and Cognitive Health More Than Other Exercise
A meta-analysis of 27 studies involving 1,392 participants reveals that structured dance interventions lasting at least six weeks significantly improve psychological and cognitive health, potentially exceeding the benefits of other forms of exercise, particularly regarding motivation and adherence; ...
Progress
36% Bias Score

Stem-Cell Transplants Show Promise in Parkinson's Treatment
Two small studies revealed stem-cell transplants significantly eased Parkinson's symptoms in patients, with one showing a 20-point improvement on a standard scale; the FDA approved one treatment for a final-stage trial before potential approval, offering hope for the 1 million Americans with this di...

Stem-Cell Transplants Show Promise in Parkinson's Treatment
Two small studies revealed stem-cell transplants significantly eased Parkinson's symptoms in patients, with one showing a 20-point improvement on a standard scale; the FDA approved one treatment for a final-stage trial before potential approval, offering hope for the 1 million Americans with this di...
Progress
44% Bias Score

Increased Microplastics in Human Brains Linked to Rising Plastic Production
A new study published in Nature Medicine reveals a significant increase in microplastic levels in human brains between 1997 and 2024, with polyethylene accounting for 75% of the particles, potentially linking increased plastic production to neurological health impacts.

Increased Microplastics in Human Brains Linked to Rising Plastic Production
A new study published in Nature Medicine reveals a significant increase in microplastic levels in human brains between 1997 and 2024, with polyethylene accounting for 75% of the particles, potentially linking increased plastic production to neurological health impacts.
Progress
16% Bias Score

Brain-on-a-Chip Improves Alzheimer's Drug Development
The International Iberian Nanotechnology Laboratory (INL) developed a brain-on-a-chip microdevice using microfluidics and a bio-membrane to simulate the blood-brain barrier, enabling more efficient testing of Alzheimer's drugs and reducing reliance on animal testing, potentially accelerating new tre...

Brain-on-a-Chip Improves Alzheimer's Drug Development
The International Iberian Nanotechnology Laboratory (INL) developed a brain-on-a-chip microdevice using microfluidics and a bio-membrane to simulate the blood-brain barrier, enabling more efficient testing of Alzheimer's drugs and reducing reliance on animal testing, potentially accelerating new tre...
Progress
32% Bias Score
Showing 1 to 9 of 9 results